Singapore markets close in 4 hours 30 minutes
Straits Times Index
3,147.55 +31.24 (+1.00%) Nikkei
26,347.68 +173.70 (+0.66%) Hang Seng
17,466.89 +216.01 (+1.25%) FTSE 100
7,005.39 +20.80 (+0.30%) BTC-USD
19,533.41 +750.67 (+4.00%) CMC Crypto 200
446.46 +17.68 (+4.12%)
PAVmed Inc. (PAVM)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.9401 |
| Open | 0.9406 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 2200 |
| Day's range | 0.9401 - 1.0100 |
| 52-week range | 0.8200 - 8.9700 |
| Volume | |
| Avg. volume | 950,455 |
| Market cap | 88.46M |
| Beta (5Y monthly) | 0.46 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.7200 |
| Earnings date | 14 Nov 2022 - 18 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.44 |
- Business Wire
PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference
NEW YORK, August 30, 2022--PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference
- Business Wire
PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results
NEW YORK, August 16, 2022--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and presented financial results for the three and six months ended June 30, 2022.
- Business Wire
Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results
NEW YORK, August 15, 2022--Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results
© 2022 Yahoo. All rights reserved.
